Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?

OBJECTIVES: To explore whether the optimal adjuvant treatments for patients with early-stage endometrial cancer with high-intermediate risk (HIR) factors should depend on tumor grade. METHODS: A retrospective analysis of patients with HIR endometrial cancer from 1999 to 2012 was conducted. The adjuv...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Chunyan, Huang, Xin, Huang, Qidan, Wang, Yin, Gu, Haifeng, Li, Yong, Liu, Jihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Uterine Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106082/
https://www.ncbi.nlm.nih.gov/pubmed/26397067
http://dx.doi.org/10.1097/IGC.0000000000000572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106082/
https://www.ncbi.nlm.nih.gov/pubmed/26397067
http://dx.doi.org/10.1097/IGC.0000000000000572

Ejemplares similares